DNA REPAIR DISORDER

Clinical trials for DNA REPAIR DISORDER explained in plain language.

Never miss a new study

Get alerted when new DNA REPAIR DISORDER trials appear

Sign up with your email to follow new studies for DNA REPAIR DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Major trial aims to stop colon Cancer's return with Immune-Boosting drug

Disease control Ongoing

This study is for people with stage III colon cancer that has a specific genetic feature (dMMR). It compares the standard chemotherapy treatment (FOLFOX) to that same chemotherapy plus an immunotherapy drug called atezolizumab. The goal is to see if adding the immunotherapy helps…

Matched conditions: DNA REPAIR DISORDER

Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC

DNA REPAIR DISORDER

Get alerted when new DNA REPAIR DISORDER trials appear

Major trial aims to stop colon Cancer's return with Immune-Boosting drug